Long‐term outcome of patients with gastric varices treated by balloon‐occluded retrograde transvenous obliteration. Issue 5 (May 2014)

• Record Type: Journal Article
• Authors: Naeshiro, Noriaki; Aikata, Hiroshi; Kakizawa, Hideaki; Hyogo, Hideyuki; Kan, Hiromi; Fujino, Hatsue; Kobayashi, Tomoki; Fukuhara, Takayuki; Honda, Yohji; Ohno, Atsushi; Miyaki, Daisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiraga, Nobuhiko; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Takahashi, Shoichi; Awai, Kazuo; Chayama, Kazuaki
• Is Part Of: Journal of gastroenterology and hepatology. Volume 29:Issue 5(2014:May)
• Page Start: 1035
• Page End: 1042
• Publication Date: 2014-05
• Subjects: Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.12508
• Languages: English
• ISSNs: 0815-9319

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="jgh12508-sec-0001" sec-type="section"> <title>Background and Aim</title> <p>To assess the short‐ and long‐term outcome of patients with gastric varices (GV) after balloon‐occluded retrograde transvenous obliteration (B‐RTO) by comparing bleeding cases with prophylactic cases.</p> </sec> <sec id="jgh12508-sec-0002" sec-type="section"> <title>Methods</title> <p>Consecutive 100 patients with GV treated by B‐RTO were enrolled in this retrospective cohort study. We compared the technical success, complications, and survival rates between bleeding and prophylactic cases.</p> </sec> <sec id="jgh12508-sec-0003" sec-type="section"> <title>Results</title> <p>Of 100 patients, 61 patients were bleeding cases and 39 patients were prophylactic cases. Technical success was achieved in 95% of bleeding case and in 100% of prophylactic case, with no significant difference between these groups (overall technical success rate, 97%). The survival rates at 5 and 10 years were 50% and 22% in bleeding case, and 49% and 36% in prophylactic case, respectively. There was also no significant difference (<italic>P</italic> = 0.420). By multivariate analysis, survival rates correlated significantly with liver function (hazard ratio 2.371, 95% CI 1.457–3.860, <italic>P</italic> = 0.001) and hepatocellular carcinoma development (HR 4.782, 95% CI 2.331–9.810, <italic>P</italic> < 0.001). The aggravating rates of esophageal varices (EV) were 21%, 50%, and 54% at 12, 60, and 120 months after B‐RTO. By multivariate analysis, aggravating rates significantly correlated with EV existing before B‐RTO (HR 18.114, 95% CI 2.463–133.219, <italic>P</italic> = 0.004).</p> </sec> <sec id="jgh12508-sec-0004" sec-type="section"> <title>Conclusion</title> <p>B‐RTO for GV could provide the high rate of complete obliteration and favorable long‐term prognosis even in bleeding cases as well as prophylactic cases. Management of EV after B‐RTO, especially in coexisting case of GV and EV, would be warranted.</p> </sec> </abstract>